During the past decade, AOU Careggi; SOD Malattie Emorragiche conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "AOU Careggi; SOD Malattie Emorragiche" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "AOU Careggi; SOD Malattie Emorragiche" are "Hemophilia A" (4 trials), "Severe Hemophilia A" (2 trials), "Haemophilia A" (1 trials), "Moderate Hemophilia A" (1 trials) and "Moderate Hereditary Factor VIII Deficiency Disease Without Inhibitor" (1 trials). Many other conditions were trialed in "AOU Careggi; SOD Malattie Emorragiche" in a lesser frequency.

Most popular intervention types in "AOU Careggi; SOD Malattie Emorragiche" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Emicizumab" (5 trials), "Bypassing Agents" (1 trials), "FVIII Replacement" (1 trials), "Factor VIII (FVIII)" (1 trials) and "Standard of Care for Haemophilia A" (1 trials). Other intervention names were less common.

The vast majority of trials in "AOU Careggi; SOD Malattie Emorragiche" are 7 trials for "All" genders.

Currently, there are NaN active trials in "AOU Careggi; SOD Malattie Emorragiche". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in AOU Careggi; SOD Malattie Emorragiche, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AOU Careggi; SOD Malattie Emorragiche, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".